![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 1
2022
Pavic, M. 
ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]
ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]